MX353954B - Aptameros y metodos de diagnostico para detectar el receptor del factor de crecimiento epidermal (egf). - Google Patents
Aptameros y metodos de diagnostico para detectar el receptor del factor de crecimiento epidermal (egf).Info
- Publication number
- MX353954B MX353954B MX2014007890A MX2014007890A MX353954B MX 353954 B MX353954 B MX 353954B MX 2014007890 A MX2014007890 A MX 2014007890A MX 2014007890 A MX2014007890 A MX 2014007890A MX 353954 B MX353954 B MX 353954B
- Authority
- MX
- Mexico
- Prior art keywords
- aptamers
- egf receptor
- detecting
- diagnostic methods
- diagnostic
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/16—Aptamers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/317—Chemical structure of the backbone with an inverted bond, e.g. a cap structure
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
- C12N2310/3513—Protein; Peptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
- C12N2310/3517—Marker; Tag
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/10—Applications; Uses in screening processes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/71—Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a aptámeros que se unen específicamente al receptor del EGF en una muestra, y a métodos de diagnóstico y analíticos usando estos aptámeros.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161582111P | 2011-12-30 | 2011-12-30 | |
US201261649168P | 2012-05-18 | 2012-05-18 | |
US201261655404P | 2012-06-04 | 2012-06-04 | |
PCT/US2012/072101 WO2013102101A1 (en) | 2011-12-30 | 2012-12-28 | Aptamers and diagnostic methods for detecting the egf receptor |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2014007890A MX2014007890A (es) | 2014-09-26 |
MX353954B true MX353954B (es) | 2018-02-07 |
Family
ID=48698659
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018004950A MX2018004950A (es) | 2011-12-30 | 2012-12-28 | Aptámeros y métodos de diagnóstico para detectar el receptor de egf. |
MX2014008104A MX355567B (es) | 2011-12-30 | 2012-12-28 | Aptameros y metodos de diagnostico para detectar el receptor de egf. |
MX2014007890A MX353954B (es) | 2011-12-30 | 2012-12-28 | Aptameros y metodos de diagnostico para detectar el receptor del factor de crecimiento epidermal (egf). |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018004950A MX2018004950A (es) | 2011-12-30 | 2012-12-28 | Aptámeros y métodos de diagnóstico para detectar el receptor de egf. |
MX2014008104A MX355567B (es) | 2011-12-30 | 2012-12-28 | Aptameros y metodos de diagnostico para detectar el receptor de egf. |
Country Status (4)
Country | Link |
---|---|
US (3) | US9316647B2 (es) |
EP (3) | EP2798085B1 (es) |
MX (3) | MX2018004950A (es) |
WO (2) | WO2013102096A1 (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10155988B2 (en) * | 2010-04-07 | 2018-12-18 | Board Of Regents, The University Of Texas System | Methods of detecting tumor cells |
US9316647B2 (en) * | 2011-12-30 | 2016-04-19 | Somalogic, Inc. | Aptamers and diagnostic methods for detecting the EGF receptor |
KR102348283B1 (ko) | 2013-09-24 | 2022-01-10 | 소마로직, 인크. | 멀티앱타머 표적 검출 |
KR101680335B1 (ko) | 2015-05-29 | 2016-11-28 | 포항공과대학교 산학협력단 | 상피세포 성장인자 수용체 압타머 및 이를 포함하는 항암제 조성물 |
EP3405577B8 (en) | 2016-01-20 | 2023-02-15 | 396419 B.C. Ltd. | Compositions and methods for inhibiting factor d |
KR101859615B1 (ko) * | 2016-07-14 | 2018-05-18 | 충북대학교 산학협력단 | 표피 성장 인자 수용체 특이적 결합 dna 앱타머 및 이의 용도 |
WO2018136827A1 (en) | 2017-01-20 | 2018-07-26 | Vitrisa Therapeutics, Inc. | Stem-loop compositions and methods for inhibiting factor d |
WO2019022986A1 (en) * | 2017-07-24 | 2019-01-31 | Vitrisa Therapeutics, Inc. | NUCLEIC ACID COMPOSITIONS AND METHODS OF INHIBITING D-FACTOR |
US11231420B2 (en) | 2018-04-09 | 2022-01-25 | Aptalogic, Inc. | Selection and optimization of aptamers to recognize ebola markers |
RU2700097C1 (ru) * | 2018-12-26 | 2019-09-12 | Общество С Ограниченной Ответственностью "Апто-Фарм" | ДНК-аптамер, связывающий внеклеточный домен EGFR |
RU2736790C1 (ru) * | 2019-10-31 | 2020-11-20 | Общество С Ограниченной Ответственностью "Апто-Фарм" | Модифицированные 50-звенные ДНК-аптамеры, связывающие внеклеточный домен EGFR |
Family Cites Families (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4800159A (en) | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
GB8822228D0 (en) | 1988-09-21 | 1988-10-26 | Southern E M | Support-bound oligonucleotides |
US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
US5800992A (en) | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
US5962219A (en) | 1990-06-11 | 1999-10-05 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: chemi-selex |
US5705337A (en) | 1990-06-11 | 1998-01-06 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: chemi-SELEX |
US5567588A (en) | 1990-06-11 | 1996-10-22 | University Research Corporation | Systematic evolution of ligands by exponential enrichment: Solution SELEX |
US5496938A (en) | 1990-06-11 | 1996-03-05 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligands to HIV-RT and HIV-1 rev |
US5580737A (en) | 1990-06-11 | 1996-12-03 | Nexstar Pharmaceuticals, Inc. | High-affinity nucleic acid ligands that discriminate between theophylline and caffeine |
US5660985A (en) | 1990-06-11 | 1997-08-26 | Nexstar Pharmaceuticals, Inc. | High affinity nucleic acid ligands containing modified nucleotides |
US5707796A (en) | 1990-06-11 | 1998-01-13 | Nexstar Pharmaceuticals, Inc. | Method for selecting nucleic acids on the basis of structure |
US5714327A (en) | 1990-07-19 | 1998-02-03 | Kreatech Diagnostics | Platinum-containing compounds, methods for their preparation and applications thereof |
NL9001639A (nl) | 1990-07-19 | 1992-02-17 | Amc Amsterdam | Pt-houdende verbinding, werkwijze voor de bereiding ervan, alsmede toepassing van dergelijke verbindingen. |
US5763170A (en) | 1991-04-16 | 1998-06-09 | Amersham International Plc | Method for forming an array of biological particles |
US5582981A (en) | 1991-08-14 | 1996-12-10 | Gilead Sciences, Inc. | Method for identifying an oligonucleotide aptamer specific for a target |
US5756291A (en) | 1992-08-21 | 1998-05-26 | Gilead Sciences, Inc. | Aptamers specific for biomolecules and methods of making |
US5580972A (en) | 1993-06-14 | 1996-12-03 | Nexstar Pharmaceuticals, Inc. | Purine nucleoside modifications by palladium catalyzed methods |
US5719273A (en) | 1993-06-14 | 1998-02-17 | Nexstar Pharmaceuticals, Inc. | Palladium catalyzed nucleoside modifications methods using nucleophiles and carbon monoxide |
US5428149A (en) | 1993-06-14 | 1995-06-27 | Washington State University Research Foundation | Method for palladium catalyzed carbon-carbon coulping and products |
US5837832A (en) | 1993-06-25 | 1998-11-17 | Affymetrix, Inc. | Arrays of nucleic acid probes on biological chips |
US5599695A (en) | 1995-02-27 | 1997-02-04 | Affymetrix, Inc. | Printing molecular library arrays using deprotection agents solely in the vapor phase |
US5945527A (en) | 1996-05-30 | 1999-08-31 | Nexstar Pharmaceuticals, Inc. | Palladium catalyzed nucleoside modification methods using nucleophiles and carbon monoxide |
US20070166741A1 (en) | 1998-12-14 | 2007-07-19 | Somalogic, Incorporated | Multiplexed analyses of test samples |
US6235504B1 (en) | 1999-01-11 | 2001-05-22 | The Rockefeller University | Methods for identifying genomic equivalent markers and their use in quantitating cells and polynucleotide sequences therein |
US6277581B1 (en) | 1999-03-01 | 2001-08-21 | Lankenau Medical Research Center | ODC allelic analysis method for assessing carcinogenic susceptibility |
US20040142384A1 (en) | 2003-01-16 | 2004-07-22 | Cohen Barb Ariel | Magnetic separator |
US8329408B2 (en) | 2005-10-31 | 2012-12-11 | Bayer Healthcare Llc | Methods for prognosis and monitoring cancer therapy |
EP1996193A2 (en) * | 2006-03-13 | 2008-12-03 | OSI Pharmaceuticals, Inc. | Combined treatment with an egfr kinase inhibitor and an agent that sensitizes tumor cells to the effects of egfr kinase inhibitors |
BRPI0717416A2 (pt) | 2006-09-21 | 2013-11-12 | Prometheus Lab Inc | Método para realizar um imunoensaio complexo de alta produtividade, e, arranjo |
EP2083269B1 (en) * | 2006-09-27 | 2013-09-04 | National University Corporation Tokyo University of Agriculture and Technology | Method of assaying target substance in sample, aptamer molecule and method of constructing the same |
US8975026B2 (en) * | 2007-01-16 | 2015-03-10 | Somalogic, Inc. | Method for generating aptamers with improved off-rates |
US7964356B2 (en) | 2007-01-16 | 2011-06-21 | Somalogic, Inc. | Method for generating aptamers with improved off-rates |
US7855054B2 (en) | 2007-01-16 | 2010-12-21 | Somalogic, Inc. | Multiplexed analyses of test samples |
US7947447B2 (en) | 2007-01-16 | 2011-05-24 | Somalogic, Inc. | Method for generating aptamers with improved off-rates |
WO2008125633A2 (en) | 2007-04-13 | 2008-10-23 | Rikshospitalet - Radiumhospitalet Hf | Egfr inhibitors for treatment and diagnosis of metastatic prostate cancer |
CN104593373A (zh) | 2007-07-17 | 2015-05-06 | 私募蛋白质体公司 | 产生具有改良的解离速率的适配体的方法 |
US8404830B2 (en) * | 2007-07-17 | 2013-03-26 | Somalogic, Inc. | Method for generating aptamers with improved off-rates |
US20090215050A1 (en) | 2008-02-22 | 2009-08-27 | Robert Delmar Jenison | Systems and methods for point-of-care amplification and detection of polynucleotides |
EP2618146B1 (en) * | 2008-02-25 | 2015-06-17 | Nestec S.A. | Drug selection for breast cancer therapy using antibody-based arrays |
WO2010108126A2 (en) * | 2009-03-19 | 2010-09-23 | Fate Therapeutics, Inc. | Reprogramming compositions and methods of using the same |
ITRM20100536A1 (it) * | 2010-10-12 | 2012-04-12 | Consiglio Nazionale Ricerche | Aptamero inibitore di egfr per uso in terapia e diagnosi |
JP5907678B2 (ja) | 2011-07-20 | 2016-04-26 | オリンパス株式会社 | 医療用動作機構およびマニピュレータ |
US9316647B2 (en) * | 2011-12-30 | 2016-04-19 | Somalogic, Inc. | Aptamers and diagnostic methods for detecting the EGF receptor |
-
2012
- 2012-12-28 US US14/365,332 patent/US9316647B2/en active Active
- 2012-12-28 EP EP12861230.6A patent/EP2798085B1/en active Active
- 2012-12-28 WO PCT/US2012/072094 patent/WO2013102096A1/en active Application Filing
- 2012-12-28 MX MX2018004950A patent/MX2018004950A/es unknown
- 2012-12-28 MX MX2014008104A patent/MX355567B/es active IP Right Grant
- 2012-12-28 WO PCT/US2012/072101 patent/WO2013102101A1/en active Application Filing
- 2012-12-28 EP EP17201582.8A patent/EP3335714A1/en not_active Withdrawn
- 2012-12-28 MX MX2014007890A patent/MX353954B/es active IP Right Grant
- 2012-12-28 US US14/369,398 patent/US9651556B2/en active Active
- 2012-12-28 EP EP12863462.3A patent/EP2797603B1/en active Active
-
2017
- 2017-05-05 US US15/587,851 patent/US10620210B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20140296501A1 (en) | 2014-10-02 |
MX2014007890A (es) | 2014-09-26 |
MX355567B (es) | 2018-04-23 |
US9651556B2 (en) | 2017-05-16 |
US20170328909A1 (en) | 2017-11-16 |
EP2798085B1 (en) | 2018-01-24 |
WO2013102096A1 (en) | 2013-07-04 |
US10620210B2 (en) | 2020-04-14 |
EP2797603B1 (en) | 2019-02-20 |
EP2798085A1 (en) | 2014-11-05 |
US9316647B2 (en) | 2016-04-19 |
EP3335714A1 (en) | 2018-06-20 |
MX2018004950A (es) | 2022-01-24 |
WO2013102101A1 (en) | 2013-07-04 |
MX2014008104A (es) | 2015-09-25 |
EP2797603A1 (en) | 2014-11-05 |
EP2797603A4 (en) | 2015-07-08 |
US20150086996A1 (en) | 2015-03-26 |
EP2798085A4 (en) | 2015-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX353954B (es) | Aptameros y metodos de diagnostico para detectar el receptor del factor de crecimiento epidermal (egf). | |
IL257714B (en) | Systems and methods for the analysis of multiple analytes | |
HK1201577A1 (en) | Point-of care immunoassay for quantitative small analyte detection | |
EP2715772A4 (en) | ION SOURCE FOR DIRECT ANALYSIS OF SAMPLES | |
EP2844768A4 (en) | DIGITAL ANALYSIS OF ANALYTES | |
EP3425063C0 (en) | PROCEDURE FOR DETECTING ANALYTES | |
EP2803673A4 (en) | MONOCLONAL ANTIBODY FOR THE DETECTION OF EXOSOMES | |
EP2887058A4 (en) | SAMPLE ANALYSIS PROCEDURE | |
EP2678682A4 (en) | BIOLOGICAL MARKERS PANEL, DIAGNOSTIC METHODS AND TESTING NEEDS FOR OVARIAN CANCER | |
BR112014012590A8 (pt) | Anticorpos anti-cd98 e métodos de uso dos mesmos | |
EP2847606A4 (en) | ANALYSIS FOR THE QUANTIFICATION OF MICROSCOPIC DIFFUSION ANISOTROPY | |
EP2902764A4 (en) | DEFECT ANALYSIS DEVICE, DEFECT ANALYSIS PROCEDURE AND PROGRAM | |
EP2844373A4 (en) | METHOD FOR ANALYZING SAMPLE COMPONENTS | |
ZA201404463B (en) | Detecting analytes | |
AU347210S (en) | Analyte test meter | |
EP2690444A4 (en) | SAMPLE ANALYSIS DEVICE | |
EP2844773A4 (en) | ANALYSIS OF BIOMARKERS USING SCODAPHORESIS | |
EP2950099A4 (en) | PROCESS FOR PREPARING A SAMPLE FOR THE DETECTION OF HBS ANTIGEN AND USE THEREOF | |
EP2771688A4 (en) | FREE PSA ANTIBODY AS A MEDIUM FOR DIAGNOSIS, FORECAST AND THERAPY OF PROSTATE CANCER | |
MX2015004419A (es) | Deteccion de analito y determinacion de concentracion de analito mediante uso de perlas magnetizables. | |
EP2856110A4 (en) | QUALITY DETERMINATION OF SERUM SAMPLE | |
EP2799883A4 (en) | SAMPLE PRE-PROCESSING SYSTEM SUPPORTING MULTI-SYSTEM CONFIGURATION | |
MX2014003137A (es) | Inmunoensayo para detectar antiobioticos. | |
HK1220255A1 (zh) | 檢測分子的方法 | |
EP2902783A4 (en) | ADDITIVE FOR MEASURING A DILUTED SAMPLE USING A REAGENT IN AN IMMUNOCHROMATOGRAPHIC METHOD WITHOUT DILUTION |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |